TP53 and cervical carcinoma: Han et al. showed that p53 delivery by a polyamidoamine derivative (AP-PAMAM) achieved an antiproliferative effect by the activation of a mitochondrial-dependent apoptosis pathway and the induction of cell cycle arrest at S phase, in addition to suppressing the cell migration and invasion of cervical cancer cells [37].